WC
HALO icon

Wexford Capital’s Halozyme HALO Stock Holding History

Wexford Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-954
Closed -$70K – 442
2025
Q3 		$70K Buy
+954
New +$63.4K 0.01% 269

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wexford Capital's HALO Position: Q4 2025 in Review

Wexford Capital sold out of Halozyme (HALO) in Q4 2025, closing a stake of 954 shares — an estimated $70K sold.

Wexford Capital first reported a position in HALO in Q3 2025 and held it in 1 quarter. The position peaked at $70K in Q3 2025. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Wexford Capital reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Wexford Capital sold 954 Halozyme shares in Q4 2025, an estimated $70K.
  • Wexford Capital first reported a position in Halozyme in Q3 2025 and held it in 1 quarter.
  • Wexford Capital's Halozyme position peaked at $70K in Q3 2025.
  • 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Wexford Capital's 13F filing for Q4 2025, filed 13 Feb 2026.